Stock Fundamentals

Company Information

Company Name
Third Harmonic Bio Inc.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US88427A1079
CIK: 0001923840
CUSIP: 88427A107
Currency: USD
Full Time Employees: 31
Phone: 209 727 2457
Fiscal Year End: December
IPO Date: Sep 14, 2022
Description:

Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of dermal, respiratory, and gastrointestinal inflammatory diseases. The company develops oral small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It also develops THB335, an oral small molecule KIT inhibitor for the treatment of mast cell-mediated inflammatory diseases, respiratory, and gastrointestinal conditions. It has a license agreement with Novartis Pharma AG. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in San Francisco, California.

Address:

1700 Montgomery Street, San Francisco, CA, United States, 94111

Directors & Officers

Name Title Year Born
Ms. Natalie C. Holles CEO & Director 1973
Mr. Christopher M. Murphy Chief Financial & Business Officer 1984
Ms. Jennifer Dittman Chief Operating Officer 1982
Ms. Julie Person Chief Administrative Officer 1974
Mr. Steven P. Sweeney Senior Vice President of Development Operations NA
Dr. Edward R. Conner M.D. Chief Medical Officer 1973
Mr. Dennis Dean Ph.D. Chief Non-Clinical Development Officer 1962
Ommer Chohan Treasurer & Secretary NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Nov 08, 2024 Edward R. Conner N/A Sale 2.12K $15.00 $31.76K
Oct 28, 2024 Edward R. Conner N/A Sale 2.67K $15.00 $40.10K
Sep 19, 2024 Edward R. Conner N/A Sale 4.79K $15.00 $71.85K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Orbimed Advisors, LLC 5.78M Jun 30, 2025 12.81% $0.78 0.00%
BML Capital Management LLC 3.82M Jun 30, 2025 8.47% $15.71 0.00%
Nantahala Capital Management, LLC 2.94M Jun 30, 2025 6.51% $0.63 0.00%
TCG Crossover Management, LLC 1.92M Jun 30, 2025 4.24% $1.19 -23.55%
BlackRock Inc 1.73M Jun 30, 2025 3.83% $0.00 16.69%
Vanguard Group Inc 1.30M Jun 30, 2025 2.88% $0.00 11.94%
D. E. Shaw & Co LP 1.25M Jun 30, 2025 2.77% $0.00 118.14%
TANG CAPITAL MANAGEMENT LLC 929.73K Jun 30, 2025 2.06% $0.26 0.00%
Schonfeld Strategic Advisors LLC 770.80K Jun 30, 2025 1.71% $0.03 2,460.29%
ADAR1 Capital Management LLC 622.87K Jun 30, 2025 1.38% $0.52 522.87%
Geode Capital Management, LLC 577.19K Jun 30, 2025 1.28% $0.00 12.10%
DLD Asset Management, LP 503.84K Jun 30, 2025 1.12% $0.23 0.00%
State Street Corp 468.99K Jun 30, 2025 1.04% $0.00 7.93%
Omers Administration Corp 426.90K Jun 30, 2025 0.95% $0.02 0.00%
Affinity Asset Advisors, LLC 370.00K Jun 30, 2025 0.82% $0.27 0.00%
Alpine Partners VI, LLC 334.48K Jun 30, 2025 0.74% $0.41 0.00%
Yakira Capital Management, Inc. 293.63K Jun 30, 2025 0.65% $0.54 0.00%
Morgan Stanley - Brokerage Accounts 272.47K Jun 30, 2025 0.60% $0.00 -14.69%
Gabelli Securities Inc 251.68K Jun 30, 2025 0.56% $0.21 0.00%
Alberta Investment Management Corp 239.39K Jun 30, 2025 0.53% $0.01 0.00%

Shares Statistics

Shares Outstanding: 45.13M
Shares Float: 15.60M
% Insiders: 911.40%
% Institutions: 8,011.60%
Short % Float: 5.17%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Russell 2000 ETF 603.45K 1.34% ▲ 0.00% Aug 31, 2025
2 Fidelity Small Cap Index 251.36K 0.56% ▲ 12.57% Jun 30, 2025
3 Vanguard Institutional Extnd Mkt Idx Tr 243.70K 0.54% ▼ 31.30% Jul 31, 2025
4 iShares Russell 2000 Value ETF 216.39K 0.48% ▲ 0.00% Aug 31, 2025
5 iShares Biotechnology ETF 134.48K 0.30% ▲ 0.00% Aug 31, 2025
6 Vanguard Russell 2000 ETF 120.16K 0.27% ▼ 6.05% Jul 31, 2025
7 Fidelity Extended Market Index 114.82K 0.25% ▼ 0.82% Jul 31, 2025
8 Schwab US Small-Cap ETF™ 98.32K 0.22% ▲ 0.00% Aug 30, 2025
9 State St Russell Sm Cap® Indx SL Cl I 93.00K 0.21% ▲ 0.00% Aug 31, 2025
10 Schwab Small Cap Index 63.41K 0.14% ▲ 0.00% Jul 31, 2025

Valuation Metrics

Enterprise Value: $-25.82M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $242.79M
EBITDA: $-64.25M
Book Value: $6.06
Earnings/Share: $-1.24
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -14.60%
ROE (TTM): -19.94%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2024-12-31 40.87x 0.00x 0.03x N/A -0.02x
2023-12-31 50.29x 0.01x 0.03x N/A -0.05x
2022-12-31 51.80x 0.00x 0.03x -14.77x -0.02x
2021-12-31 22.72x 0.00x 1.36x -1.79x 0.00x
2020-12-31 3.81x 0.00x 3.18x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about THRD.US!